Title for MeetingAbstracts
Alphabetical listing of titles
Amphotericin B in the treatment and prevention of AIDS: selective reduction of cytotoxicity by complexing to lipids.
Amphotericin B Incorporated in Immunoliposomes to Neutralize Cell-Free HIV Particles and Virus-Infected Cells.
Amphotericin B Lipid Complex (ABLC) Is Effective against Fluconazole-resistant Candida Species Infections.
Amphotericin B Lipid Complex (ABLC) Synergizes with Pulmonary Alveolar Macrophages to Destroy Conidia of Aspergillus fumigatus.
Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: a multicenter, open-label with blinded centralized randomization and parallel clinical trial.
Amphotericin B lipid complex vs meglumine antimoniate in the treatment of visceral leishmaniasis in HIV-infected patients: a multicenter, open label, blinded, randomization, parallel controlled clinical trial.
Amphotericin B lipid emulsions: a promising alternative formulation to the conventional dosage form.
Amphotericin B, Azole, and 5-Flucytosine Pharmacodynamic Parameters in the Presence of Human Serum.
Amphotericin B-Induced Differential Expression of Genes Encoding Immunomodulatory Proteins in Human Monocytic Cells Detected by cDNA Microarray.
Amphotericin B-induced Differential Expression of Genes in Human Mast Cells Detected by cDNA Microarray.
Amphotericin B-lipid complex (ABLC) in treatment of cryptococcal meningitis in AIDS.
Amphotericin B-Mediated Killing of Candida albicans is not Calcium Dependent.
Amphotericin b-Resistant Candida krusei? A Comparison of Standardized Testing and Time Kill Studies.
Amphotericin combined with itraconazole is superior to amphotericin alone in cryptococcal meningitis.